Prevalence of plasma lipid abnormalities in Saudi children

M A El-Hazmi1, A S Warsy

  • 1Medical Biochemistry Department and WHO Collaborating Centre for Hemoglobinopathies, Thalassaemias and Enzymopathies, College of Medicine and KKUH, Riyadh, Saudi Arabia.

Annals of Saudi Medicine
|February 1, 2007
PubMed

Insights

This study assessed lipid levels in Saudi children, finding that 7.72% had borderline high cholesterol and 1.4% had borderline high triglycerides, indicating a need for lipid awareness programs.

Area of Science:

  • Pediatric lipidology
  • Cardiovascular disease risk factors in children
  • Public health and epidemiology

Background:

  • Pediatric lipid levels exhibit population-specific variations.
  • Elevated lipid levels in children are linked to atherosclerosis development.
  • Investigating childhood lipid profiles is crucial for long-term cardiovascular health.

Purpose of the Study:

  • To determine the prevalence of dyslipidemia in Saudi children.
  • To assess cardiovascular disease risk based on lipid profiles in pediatric populations.
  • To inform the development of targeted health interventions.

Main Methods:

  • A national household screening program included 2914 children aged 1 to <15 years.
  • Fasting blood samples were analyzed for triglyceride and cholesterol levels.
  • Prevalence of borderline and high-risk lipid levels was calculated using established guidelines.

Main Results:

  • Overall cholesterol ranged from 2.0-5.7 mmol/L; triglyceride levels ranged from 0.1-1.7 mmol/L.
  • 7.72% of children were in the borderline risk group and 1.55% in the high-risk group for cholesterol.
  • 1.4% were in the borderline risk group and 0.55% in the high-risk group for triglycerides, with variations across age groups.

Conclusions:

  • The study highlights the prevalence of dyslipidemia in Saudi children.
  • There is a clear need for a lipid awareness program targeting Saudi children.
  • Early intervention can mitigate future adult dyslipidemia complications.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...